[1]
K. Kister, A. Makarewicz, M. Dzikowski, E. Drzał, and P. Wróbel-Knybel, “Safety of pharmacotherapy with Selective Serotonin Reuptake Inhibitors in patients on the autism spectrum - Case report”, Curr Probl Psychiatry, vol. 25, pp. 264–274, Jan. 2025, doi: 10.12923/2353-8627/2024-0025.